GUY J. LAIDIG,MARK S. SMYTH,CATHERINE SYLVAIN,HAN-JIE ZHOU,KEVIN D. SHENK,FRANCESCO PARLATI,MARK K. BENNETT
申请号：
PT07809745
公开号：
PT2041158E
申请日:
2007.06.19
申请国别(地区):
PT
年份:
2013
代理人:
摘要：
One aspect of the invention relates to inhibitors of formula (I) that preferentially inhibit immunoproteasome activity over constitutive proteasome activity. In certain embodiments, the invention relates to the treatment of immune related diseases, comprising administering a compound of the invention. In certain embodiments, the invention relates to the treatment of cancer, comprising administering a compound of the invention.
